Novo Nordisk Foundation
Distinguished Innovator Grant – Health
Last verified:
Details
| Funder | Novo Nordisk Foundation |
| Budget | Up to DKK 7.6 million |
| Duration | 3 years |
| Consortium | No |
| Frequency | Annual |
| Eligible countries | DKFIISNOSE |
Eligibility & scope
For senior faculty/researchers at Nordic research institutions or hospitals with a proven innovation track record (patents, spinouts). Covers med-tech, industrial biotech, pharma, quantum tech; focus on cardiometabolic and infectious diseases. Projects must have commercialisation outlook; pre-CVR only. Administered by non-profit; companies ineligible.
More from Novo Nordisk Foundation
Interdisciplinary Synergy Programme 2026
Deadline: 20 May 2026Up to DKK 19.4 million per grantNovo Nordisk Foundation Interdisciplinary Synergy Programme 2026
Deadline: 20 May 2026Up to DKK 19.4M (~€2.6M)Steno Collaborative Grants
Deadline: 2 Jun 2026DKK 1M–DKK 10M per grant (total pool up to DKK 30M)Non-Diabetic Endocrinology Collaborative Grants 2026
Deadline: 3 Jun 2026DKK 5M–10M per grant (total pool up to DKK 53M)Project grants in Endocrinology and Metabolism – Nordic Region
Deadline: 4 Jun 2026Up to DKK 4.5 million per grant
Does this grant match your research?
Sign up free to get a personalised match score and weekly alerts for grants like this.
Get started free